ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 891,76
0,76%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Laboratory Corporation of America Holdings (LH)

  7. Laboratory Corporation of America Holdings (LH) Actualités

LH Laboratory Corporation of America Holdings

198,40
0,05 (0,03%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Laboratory Corporation of America Holdings LH NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,05 0,03% 198,40 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
197,08 197,01 200,155 198,40 198,35
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202412:58PRNUSLabcorp Announces 2024 First Quarter Results
25/4/202403:27PRNUSLabcorp Announces Winning Bid for Select Assets of Invitae
25/4/202403:19PRNUSInvitae Enters into Agreement with Labcorp for Sale of..
15/4/202413:00PRNUSLabcorp Announces First-of-Its-Kind Test for Early..
11/4/202412:59PRNUSLabcorp Declares Quarterly Dividend
10/4/202412:49PRNUSLabcorp Receives FDA Emergency Use Authorization for Mpox..
08/4/202413:00PRNUSLabcorp Announces Expansion of Precision Oncology Portfolio..
05/4/202413:00PRNUSLabcorp Launches Labcorp® Plasma Detect™ Extending..
02/4/202413:00PRNUSLabcorp to Present Diverse Portfolio of Precision Oncology..
01/4/202414:00BWXcell Biosciences Strengthens Cell and Gene Therapy..
29/3/202414:00PRNUSThe Prelude Network® Names Labcorp Its Preferred Genetic..
28/3/202413:00PRNUSLabcorp Announces Acquisition of Select Assets of..
27/3/202412:00PRNUSLabcorp to Announce First Quarter Financial Results on April..
20/3/202412:00PRNUSLabcorp Launches pTau217 Blood Biomarker Test to Accelerate..
16/3/202415:29PRNUSLabcorp Presents New Research Demonstrating Clinical Impact..
11/3/202413:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202413:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202419:16EDGAR2Form 144 - Report of proposed sale of securities
07/3/202416:34EDGAR2Form 144 - Report of proposed sale of securities
07/3/202413:00PRNUSLabcorp Launches Weight Loss Management Testing Solutions
22/2/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202421:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:35EDGAR2Form 144 - Report of proposed sale of securities
21/2/202420:38EDGAR2Form 144 - Report of proposed sale of securities
21/2/202414:19GLOBEDiagnostics Industry Leader Gary Huff Appointed to Biomerica..
15/2/202414:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202413:01EDGAR2Form 8-K - Current report
15/2/202412:56PRNUSLabcorp Announces 2023 Fourth Quarter and Full Year Results
13/2/202418:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:24EDGAR2Form 144 - Report of proposed sale of securities
09/2/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202421:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NYSE
LH
Laboratory Corporation o...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés